U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 100 points. Here is the list of some big stocks recording losses in the previous session.
- Y-mAbs Therapeutics, Inc. (NASDAQ: YMAB) shares tumbled 59.8% to close at $3.61 after the FDA Oncologic Drugs Advisory Committee voted Y-mAbs did not provide sufficient evidence to conclude its treatment improves overall survival.
- TuSimple Holdings Inc. (NASDAQ: TSP) declined 45.6% to close at $3.43 following a media report stating the company is being investigated over ties to a Chinese startup. TuSimple board terminated CEO, President, and Chief Technology Officer Dr. Xiaodi Hou from his position.
- Instil Bio, Inc. (NASDAQ: TIL) dropped 37.1% to close at $3.30 after the company voluntarily paused enrollment of its ongoing clinical trials.
- Golden Sun Education Group Limited (NASDAQ: GSUN) fell 18.6% to close at $21.16.
- Waterdrop Inc. (NYSE: WDH) dropped 12.2% to close at $1.30.
- Beam Therapeutics Inc. (NASDAQ: BEAM) fell 9.6% to close at $44.06.
- ON Semiconductor Corporation (NASDAQ: ON) declined 9% to close at $61.43 after the company reported Q3 financial results and issued Q4 guidance.
- Global Payments Inc. (NYSE: GPN) fell 8.8% to close at $114.26 following downbeat quarterly earnings.
- Wolfspeed, Inc. (NYSE: WOLF) dropped 8.3% to close at $78.75.
- Arcus Biosciences, Inc. (NYSE: RCUS) declined 8.2% to settle at $25.48.
- Newell Brands Inc. (NASDAQ: NWL) dropped 8.2% to close at $13.81. Barclays (LON:BARC) downgraded Newell Brands from Equal-Weight to Underweight and lowered the price target from $16 to $11.
- Coinbase (NASDAQ:COIN) Global, Inc. (NASDAQ: COIN) fell 8.1% to settle at $66.25.
- DoorDash, Inc. (NYSE: DASH) dipped 7.5% to close at $43.53.
- RLX Technology Inc. (NYSE: RLX) fell 7.4% to settle at $1.25.
- Hanesbrands Inc. (NYSE: HBI) dropped 5.3% to settle at $6.82 amid analysts at Wells Fargo (NYSE:WFC) downgrading their rating of the stock to Underweight and announcing a $5 price target.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.